Eiger BioPharmaceuticals, Inc. filed a notice for the selection of Successful Bidder in the US Bankruptcy Court for the sale of its substantially all its assets on April 19, 2024. As a result of the auction conducted on April 17, 2024, Sentynl Therapeutics, Inc., has been selected as the winning bidder for the sale of debtor?s substantially all its assets.